Rapid fatal pulmonary complications in a Chinese patient after bortezomib treatment for ALK-negative anaplastic large-cell lymphoma.
Development of fatal bortezomib induced acute lung injury despite concurrent therapy with high-dose dexamethasone.
Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma.